Emcure Pharmaceuticals Limited ( (IN:EMCURE)) has shared an announcement. Emcure Pharmaceuticals Limited has submitted a confirmation certificate to Indian stock exchanges for the quarter ended June ...

The shares of Emcure Pharmaceuticals jumped nearly 3 percent to hit a fresh record high on January 7, before erasing all gains to close in the red. An analyst has suggested which key levels investors ...

Get all latest & breaking news on Emcure Pharmaceuticals. Watch videos, top stories and articles on Emcure Pharmaceuticals at moneycontrol.com.

Emcure Pharma shares surged 10 percent on May 23, 2025 The company reported a 62 percent rise in Q4 net profit to ₹197.2 crore Revenue for Q4FY25 increased by 19 percent to ₹2,116.2 crore Emcure ...

MUMBAI (Reuters) - The U.S. Food and Drug Administration (FDA) has warned Indian generic drugmaker Emcure Pharmaceuticals, saying it repeatedly fudged test records at its plant at Hinjwadi, Pune, in ...

Pune: Emcure Pharmaceuticals Limited has announced that its subsidiary, Marcan Pharmaceuticals Inc., has entered into share ...

Emcure Pharmaceuticals has had its share of run-ins with the FDA in the past over the sterility of one of its Indian manufacturing plants. Now, it can notch one more black mark on its belt. The FDA ...

On Friday, Emcure Pharmaceuticals Ltd shares closed at ₹1,075 a share, 2.45% up on the National Stock Exchange. Mumbai: Global private equity firm Bain Capital is looking to divest its stake in listed ...

India, July 3 -- India's pharmaceutical market is changing. Investors are no longer only looking at companies that sell basic medicines at scale. The bigger interest is now moving towards companies ...

HDT Bio requested at least $950 mln in damages India-based Emcure argued that court lacked jurisdiction Dec 4 (Reuters) - Generic drugmaker Emcure Pharmaceuticals (EMCU.NS), opens new tab convinced a ...

At the pre-opening bell, the frontline index S&P BSE Sensex opened in green with a gain of 399 points or 0.52 per cent. On ...